Quick Contact

    Jeff Lindsay

    Senior Advisor

    Jeff Lindsay - ipCG

    Education

    Ph.D. in Chemical Engineering from Brigham Young University (BYU) in Provo, Utah. Fellow of the American Institute of Chemical Engineers (AICHE).

    Reads, writes, and speaks Mandarin Chinese and also speaks some German and Hmong.

    Biography

    Jeff Lindsay’s career has focused on innovation, invention, and IP protection with experience in academia, large corporations in both the US and Asia, a rapidly growing startup, and a service provider. Jeff seeks to overcome the many potential gaps between inventors and their employers as well as the gaps between corporate knowledge and the emerging possibilities in their field. Every year since 2015, Jeff has been named as “one of the world’s leading IP strategists” in the IAM Strategy 300 publication by IAM Media. Some of Jeff’s approaches are described in Conquering Innovation Fatigue (John Wiley & Sons, 2009) by Jeff Lindsay, Cheryl Perkins, and Mukund Karanjikar.

    Most recently served as Head of R&D and IP at Lume Deodorant, a startup focused on science-based consumer products for which Jeff wrote their initial patents and more recently created further IP and new product opportunities in his role there from 2019 to 2020. From 2011 to 2019, Jeff was the Head of IP at Asia Pulp & Paper (APP) in Shanghai, one of the largest paper companies in the world and part of what may be the world’s largest family-owned company, Sinar Mas out of Jakarta, Indonesia. At APP, Jeff led a team of six IP professionals in protecting APP’s brands and in providing guidance on innovation strategy.

    Jeff is also the former Corporate Patent Strategist and Senior Research Fellow for Kimberly-Clark (K-C), where he helped guide IP strategy for K-C’s many patent filing groups. At K-C, Jeff believed one of his major accomplishments was bringing the power of ipCapital Group to Kimberly-Clark to implement the Invention on Demand system and to rapidly accelerate K-C’s IP strategy. Significant IP estates were created in several areas such as RFID, business tools involving virtual and augmented reality, and a variety of emerging technologies.

    Following K-C, Jeff served as a Director at Innovationedge, a consultancy led by K-C’s former Chief Innovation Officer, Cheryl Perkins. At Innovationedge Jeff assisted companies in IP strategy, technology transfer, and technology scouting.

    Jeff is a former professor at the Institute of Paper Science and Technology (now RBI) at Georgia Tech. He is a registered US patent agent and inventor with 130 US patents. Current interests and projects include consumer product formulation, novel uses of natural ingredients in consumer products, biofilm control, odor control, facial recognition and customizable security systems using the “Private Rules” approach that he has patented.

    Jeff has a Ph.D. in Chemical Engineering from Brigham Young University (BYU) in Provo, Utah and is a Fellow of the American Institute of Chemical Engineers (AICHE). Jeff serves as a board member and a Vice President of the Interpreter Foundation (Salt Lake City, Utah). He has also served as an advisor to the Utah-Qinghai Ecopartnership and as board member for the Huang Yi Cong Foundation, one of China’s leading charitable foundations which is largely funded by APP and its employees.

    Jeff reads, writes, and speaks Mandarin Chinese and also speaks some German and Hmong.

    Articles

    Figure 01 and the Battle for Intellectual Property in Robotics!

    Figure 01 (Figure) represents a pioneering venture in the field of humanoid robotics brought forth by the collaborative efforts of startup Figure AI and OpenAI. This endeavor aims to bridge the gap between advanced artificial intelligence (AI) and practical, physical tasks by creating a humanoid robot capable of learning, adapting, and interacting with its environment […]

    The Secret IP Blueprint Tech Giants Don’t Want Startups to Know!

    In the world of startups, innovation isn’t just a buzzword—it’s your lifeline. As an IP consultant with a decade in the trenches, I’ve seen it all: from garage projects turning into Silicon Valley legends to brilliant ideas fizzling out in obscurity. Here’s what I know: the way you handle your intellectual property (IP) can make […]

    Pharma’s Secret Weapon: How Adial’s Genius IP Move Is Changing the Game

    Pharma CEOs, take note! Adial Pharmaceuticals just showcased an IP strategy worth emulating. Their recent patent for AD04, aimed at the serotonin transporter gene for addiction treatment, isn’t just a win; it’s a masterclass in strategic IP management. Precision is Key Adial’s approach? Pinpoint precision. They zeroed in on a specific genetic target, making their […]